{"id":"W4412525820","doi":"10.51731/cjht.2025.1172","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.00001645373,0.0001238916,0.00008703017,0.00003644044],"category_scores_gemma":[0.0002085749,0.00006651488,0.0000891459,0.0003240212,0.0001131661,0.00003465791,0.000009876098,0.000255158,0.000005339526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004900353,"about_ca_topic_score_gemma":0.005150814,"domain_scores_codex":[0.9991509,0.00001385038,0.0003627633,0.00008973298,0.00008906022,0.0002936485],"domain_scores_gemma":[0.9993985,0.00003065386,0.000158916,0.0002063835,0.0001254927,0.00008003504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003036438,0.00003837535,0.05262906,0.0001379032,0.000112682,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.005933478,0.04243873,0.8982967],"study_design_scores_gemma":[0.002057711,0.0009052149,0.1422066,0.001118748,0.00007087042,0.0004772586,0.001652763,0.000003718626,0.001038769,0.005022954,0.8453579,0.00008753625],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2742569,0.319737,0.0002011912,0.3987084,0.0009884798,0.0004530191,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.001844533,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.000001026661,0.000005860353,0.0002200393],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8982091,"threshold_uncertainty_score":0.9608583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842399516344367,"score_gpt":0.3173981953308042,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}